4//SEC Filing
Katz Richard D 4
Accession 0001293577-17-000002
CIK 0001105533other
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 6:58 PM ET
Size
4.9 KB
Accession
0001293577-17-000002
Insider Transaction Report
Form 4
Katz Richard D
VP & Chief Financial Officer
Transactions
- Award
Common Stock
2017-08-30+395,664→ 399,622 total
Footnotes (1)
- [F1]The shares are subject to a lapsing right of repurchase by the issuer, which shall lapse as to 197,832 shares on January 2, 2018, and with respect to the remaining 197,832 shares on January 9, 2018, subject to the Reporting Person continuing to be an employee of the issuer through each such date.
Documents
Issuer
ARGOS THERAPEUTICS INC
CIK 0001105533
Entity typeother
Related Parties
1- filerCIK 0001293577
Filing Metadata
- Form type
- 4
- Filed
- Aug 30, 8:00 PM ET
- Accepted
- Aug 31, 6:58 PM ET
- Size
- 4.9 KB